Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Growth

    Back to All Ratios
LACTOSE (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -8.5666.44-5.7996.48-31.65

What is the latest Core EBITDA Growth ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Growth ratio of LACTOSE (INDIA) is -8.56 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-8.56
Mar202466.44
Mar2023-5.79
Mar202296.48
Mar2021-31.65

How is Core EBITDA Growth of LACTOSE (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2025 -8.56
Negative
Mar2024 66.44
Positive
Mar2023 -5.79
Negative
Mar2022 96.48
Positive
Mar2021 -31.65 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Growth ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹150.3 Cr 9.6% 31.9% 19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.4% 10.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 0.7% 9.5% 16.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr -2.5% 6% 36.2% Stock Analytics
CIPLA ₹115,641.0 Cr 9.7% 16.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 4.5% 9.7% 9% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

9.6%

31.9%

19.6%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses